Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Alexander Yi

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Investigation|January 7, 2010
Pregenerative medicine: developmental paradigms in the biology of cardiovascular regenerationB Alexander Yi, Oliver Wernet, Kenneth R Chien
Nature Cell Biology|March 3, 2011
Shortcuts to making cardiomyocytesHuansheng Xu, B Alexander Yi, Kenneth R Chien
Cell Research|July 4, 2012
In vivo reprogramming for heart diseaseHuansheng Xu, B Alexander Yi, Kenneth R Chien
Clinical Pharmacology and Therapeutics|January 10, 2018
Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?Markus Hinder, B Alexander Yi, Thomas H Langenickel
Cardiology Clinics|December 30, 2008
Genetics of atrial fibrillationSteven A Lubitz, B Alexander Yi, Patrick T Ellinor
The New England Journal of Medicine|November 3, 2021
Abelacimab for Prevention of Venous Thromboembolism. ReplyJeffrey I Weitz, Gary E Raskob, B Alexander Yi
Heart Failure Clinics|March 30, 2010
Genetics of atrial fibrillationSteven A Lubitz, B Alexander Yi, Patrick T Ellinor
The Medical Clinics of North America|December 7, 2007
Genetics of atrial fibrillationPatrick T Ellinor, B Alexander Yi, Calum A MacRae
Cold Spring Harbor Perspectives in Medicine|September 5, 2013
Direct cardiomyocyte reprogramming: a new direction for cardiovascular regenerative medicineB Alexander Yi, Christine L Mummery, Kenneth R Chien
Journal of Molecular and Cellular Cardiology|July 4, 2012
Cardiomyocyte reprogramming and the new age of cellular alchemyKenneth R Chien, B Alexander Yi, Huansheng Xu, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Investigation|January 7, 2010
Pregenerative medicine: developmental paradigms in the biology of cardiovascular regenerationB Alexander Yi, Oliver Wernet, Kenneth R Chien
Nature Cell Biology|March 3, 2011
Shortcuts to making cardiomyocytesHuansheng Xu, B Alexander Yi, Kenneth R Chien
Cell Research|July 4, 2012
In vivo reprogramming for heart diseaseHuansheng Xu, B Alexander Yi, Kenneth R Chien
Clinical Pharmacology and Therapeutics|January 10, 2018
Developing Drugs for Heart Failure With Reduced Ejection Fraction: What Have We Learned From Clinical Trials?Markus Hinder, B Alexander Yi, Thomas H Langenickel
Cardiology Clinics|December 30, 2008
Genetics of atrial fibrillationSteven A Lubitz, B Alexander Yi, Patrick T Ellinor
The New England Journal of Medicine|November 3, 2021
Abelacimab for Prevention of Venous Thromboembolism. ReplyJeffrey I Weitz, Gary E Raskob, B Alexander Yi
Heart Failure Clinics|March 30, 2010
Genetics of atrial fibrillationSteven A Lubitz, B Alexander Yi, Patrick T Ellinor
The Medical Clinics of North America|December 7, 2007
Genetics of atrial fibrillationPatrick T Ellinor, B Alexander Yi, Calum A MacRae
Cold Spring Harbor Perspectives in Medicine|September 5, 2013
Direct cardiomyocyte reprogramming: a new direction for cardiovascular regenerative medicineB Alexander Yi, Christine L Mummery, Kenneth R Chien
Journal of Molecular and Cellular Cardiology|July 4, 2012
Cardiomyocyte reprogramming and the new age of cellular alchemyKenneth R Chien, B Alexander Yi, Huansheng Xu, et al.
Pageof 2